Brief: Bluejay Diagnostics Entered Into An Amended & Restated License Agreement
26/10/2023 22:12
Oct 26 (Reuters) - Bluejay Diagnostics Inc BJDX.O :
* BLUEJAY DIAGNOSTICS INC - ON OCTOBER 23 ENTERED INTO AN
AMENDED
AND RESTATED LICENSE AGREEMENT AND A MASTER SUPPLY AGREEMENT
Source text for Eikon: ID:
Further company coverage: BJDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bluejay Diagnostics
See all newsBrief: Bluejay Diagnostics Announces Successful Completion Of Enrollment In The Symon-II Multicenter Clinical Validation Study
Brief: Bluejay Diagnostics And Argonaut Manufacturing Services Announce Strategic Partnership
Bluejay Diagnostics Q1 net loss unchanged
Brief: Bluejay Diagnostics, Inc. Announces Completion Of 624 Patient Enrollments In Symon-Ii Pivotal Clinical Trial
Brief: Bluejay Diagnostics Provides Corporate Update And 2026 Strategic Outlook